Evaluation of Antiangiogenic Effects of a New Synthetic Candidate Drug KR-31831 on Xenografted Ovarian Carcinoma Using Dynamic Contrast Enhanced MRI

OBJECTIVE: The purpose of this research was to investigate the anti-angiogenic inhibitory effect of KR-31831, a newly developed anti-angiogenic agent, on an in vivo human ovarian carcinoma model using dynamic contrast-enhanced (DCE) MRI. MATERIALS AND METHODS: Xenografted ovarian tumors were establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jehoon, Kim, Jae-Hun, Im, Geun-Ho, Heo, Hyejung, Yoon, Sera, Lee, Jaewon, Lee, Jung Hee, Jeon, Pyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168802/
https://www.ncbi.nlm.nih.gov/pubmed/21927562
http://dx.doi.org/10.3348/kjr.2011.12.5.602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168802/
https://www.ncbi.nlm.nih.gov/pubmed/21927562
http://dx.doi.org/10.3348/kjr.2011.12.5.602

Ejemplares similares